A detailed history of Rhumbline Advisers transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Rhumbline Advisers holds 24,667 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,667
Previous 26,899 8.3%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
N/A
-2,232 Reduced 8.3%
24,667 $0
Q2 2024

Aug 01, 2024

BUY
N/A
25,378 Added 1668.51%
26,899 $0
Q3 2023

Nov 09, 2023

SELL
N/A
-1,637 Reduced 51.84%
1,521 $0
Q2 2023

Aug 08, 2023

SELL
N/A
-38,804 Reduced 92.47%
3,158 $0
Q1 2023

May 11, 2023

BUY
N/A
647 Added 1.57%
41,962 $158,000
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $6,109
614 Added 1.51%
41,315 $268,000
Q3 2022

Nov 10, 2022

BUY
$8.57 - $11.57 $24,167 - $32,627
2,820 Added 7.44%
40,701 $362,000
Q2 2022

Aug 11, 2022

BUY
$8.84 - $11.64 $13,003 - $17,122
1,471 Added 4.04%
37,881 $378,000
Q1 2022

May 12, 2022

SELL
$10.07 - $11.93 $31,418 - $37,221
-3,120 Reduced 7.89%
36,410 $422,000
Q4 2021

Feb 10, 2022

SELL
$7.95 - $11.24 $469 - $663
-59 Reduced 0.15%
39,530 $439,000
Q3 2021

Nov 12, 2021

BUY
$9.22 - $12.44 $6,970 - $9,404
756 Added 1.95%
39,589 $365,000
Q2 2021

Aug 05, 2021

SELL
$9.91 - $12.78 $69,924 - $90,175
-7,056 Reduced 15.38%
38,833 $437,000
Q1 2021

May 06, 2021

SELL
$10.44 - $12.22 $1,044 - $1,222
-100 Reduced 0.22%
45,889 $486,000
Q4 2020

Feb 10, 2021

BUY
$9.3 - $11.77 $50,564 - $63,993
5,437 Added 13.41%
45,989 $499,000
Q3 2020

Nov 12, 2020

SELL
$7.59 - $10.8 $46,693 - $66,441
-6,152 Reduced 13.17%
40,552 $394,000
Q2 2020

Aug 13, 2020

BUY
$7.96 - $11.54 $28,464 - $41,267
3,576 Added 8.29%
46,704 $372,000
Q1 2020

May 06, 2020

BUY
$7.69 - $11.68 $12,634 - $19,190
1,643 Added 3.96%
43,128 $375,000
Q4 2019

Feb 05, 2020

BUY
$9.09 - $11.89 $745 - $974
82 Added 0.2%
41,485 $469,000
Q3 2019

Oct 23, 2019

BUY
$9.66 - $12.36 $30,390 - $38,884
3,146 Added 8.22%
41,403 $450,000
Q2 2019

Aug 14, 2019

SELL
$9.32 - $12.98 $9,786 - $13,629
-1,050 Reduced 2.67%
38,257 $358,000
Q1 2019

May 01, 2019

BUY
$10.35 - $13.06 $9,149 - $11,545
884 Added 2.3%
39,307 $483,000
Q4 2018

Jan 31, 2019

BUY
$11.64 - $15.41 $137,258 - $181,714
11,792 Added 44.28%
38,423 $455,000
Q2 2018

Aug 06, 2018

BUY
$13.05 - $15.45 $13,506 - $15,990
1,035 Added 4.04%
26,631 $397,000
Q1 2018

May 02, 2018

SELL
$12.0 - $14.45 $14,700 - $17,701
-1,225 Reduced 4.57%
25,596 $334,000
Q4 2017

Feb 09, 2018

SELL
$11.65 - $13.35 $55,931 - $64,093
-4,801 Reduced 15.18%
26,821 $338,000
Q3 2017

Nov 06, 2017

BUY
$11.95 - $13.35 $377,882 - $422,153
31,622
31,622 $410,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.